Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AE.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.516NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-1906.48Singapore
B.1.1.526NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.279NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AE.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
N.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AE.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.201NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.221NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.410NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.411NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.109NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.361NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.38NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
A.12NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.417NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.442NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.75NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.51NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.106NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
D.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.593NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.438.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.290NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.341NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.161NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.69 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.19.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.479NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.437NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.371NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.4.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FY.6.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HU.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.1.4.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KJ.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JC.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.148NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.382NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.356NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.376NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.607NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.163NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.337NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.158NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.602NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.289NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DV.7.1.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.1.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used